Birmingham, West Midlands -- (SBWIRE) -- 01/22/2014 -- Value Penny Stocks issues special report on Peregrine Pharmaceuticals (NASDAQ:PPHM), FuelCell Energy Inc (NASDAQ:FCEL), MannKind Corporation (NASDAQ:MNKD), Chelsea Therapeutics International Ltd. (NASDAQ:CHTP).
Peregrine Pharmaceuticals (NASDAQ:PPHM) ended its recent business day with the gain of 7.56% and closed at the price of $1.85 after opening at $1.75. The stock traded during its last trading session with the total volume of 8.61 million shares, as compared to its average volume of 3.13 million shares. Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of monoclonal antibodies focused on the treatment and diagnosis of cancer. The company’s lead product candidates in development include Bavituximab, a phosphatidylserine (PS) targeting agent that completed Phase IIb second-line non-small cell lung cancer trial for the treatment of solid tumors; and Cotara.
Will PPHM Continue To Move Higher? Find Out Here
FuelCell Energy Inc (NASDAQ:FCEL) remained among the day advancers and traded with volume of 8.38 million shares in the last session, as compared to average volume of 8.13 million shares. In comparison with 52 week range of $0.84 - $1.95, it faced lowest price of $1.42 during the last trading session whereas its day highest price was $1.50. The company’s total market capitalization is $341.07 billion, along with 227.38 million shares outstanding. FuelCell Energy, Inc., together with its subsidiaries, designs, manufactures, sells, installs, operates, and services stationary fuel cell power plants for distributed baseload power generation.
Why Should Investors Buy FCEL After The Recent Gain? Just Go Here and Find Out
MannKind Corporation (NASDAQ:MNKD) showed 8.12 million shares in volume during the last trading session, while the average trading volume remained 7.24 million shares. The stock kicked off its trading session at $5.83 and closed at $5.56 after declining -3.97%. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States.
Why Should Investors Buy MNKD After the Recent Fall? Just Go Here and Find Out
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) stock traded during its last trading session with the total traded volume of 7.84 million shares versus its average volume of 5.29 million shares. The company opened its trade at the price of $4.85 and its closing price was $4.79 after gaining 0.63% for the day. Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products.
Why Should Investors Buy CHTP After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)